See related research article by Djabarouti *et al.*, <http://arthritis-research.com/content/12/6/R217>

After publication of our recent article \[[@B1]\], we noticed an error in the unit for the area under the time-concentration curve between 0 and 12 hours (AUC~0-12\ h~). Throughout the article and Table [1](#T1){ref-type="table"} the unit should be mg·h/L (mg multiplied by hour per L) not mg/hour/L.

###### 

Inclusion characteristics (of the 26 systemic lupus erythematosus patients) and their ability to predict clinical outcome (univariate analysis)

                                      Total               Successes          Failures            
  ----------------------------------- ------------------- ------------------ ------------------- ---------
  Demographic                                                                                    
   Females/Males, number              16/10               12/5               4/4                 0.28^b^
   Age, years                         46 (35-61)^a^       46.5 (35-61)       46 (38-61)          0.9
   Body weight, kg                    60 (56-75)          60 (56-75)         62 (58-82.5)        0.62
  Disease                                                                                        
   Duration before entry, months      11 (7-14)           11 (7-12)          10 (6-13)           0.30
   SLEDAI score                       0 (0-2)             0 (0-2)            0 (0-2)             0.20
   C3, g/L                            1 (0.6-1.1)         1 (0.9-1.1)        0.8 (0.56-0.96)     0.21
   C4, g/L                            0.2 (0.1-0.2)       0.2 (0.1-0.2)      0.2 (0.16-0.24)     0.78
   Anti-double-stranded DNA, IU/mL    24 (6-51)           8 (1-32)           38 (9-55)           0.19
  Biological                                                                                     
   GFR, mL/minute                     95 (67-125)         95 (67-125)        93.5 (76-109)       0.64
   Albumin, g/L                       40 (39.8-43.8)      40 (37.9-43.8)     42.8 (40-46.9)      0.33
   Aspartate aminotransferase, IU/L   23 (19-26)          23 (17.5-24.5)     28 (20-33)          0.26
   Alanine aminotransferase, IU/L     22 (15-29)          19 (13-24.5)       25 (19-37)          0.21
   γ-Glutamyltransferase, IU/L        24 (17-63)          23 (17-21)         42 (17-61)          0.92
  Treatment                                                                                      
   MMF, g/day                         2 (2-2)             2 (2-2)            2 (2-2)             0.9
   Corticosteroids, mg/day            11 (7-35)           10 (5-20)          15 (7-45)           0.37
   Months of MMF therapy              2 (1-3)             2 (1-3)            2 (1-3)             0.56
   Months of corticosteroids          10 (6-13)           10 (5-15)          9 (5-14)            0.12
  MPA pharmacokinetic parameters                                                                 
   AUC~0-12\ h\'~mg·hour/L            64.7 (38.2-82)      73.1 (61.8-95)     37.7 (32-43.7)      0.003
   C~max\'~mg/L                       16.1 (9.5-18.5)     16.3 (9.7-17.4)    13.3 (7-22.5)       0.69
   T~max\'~hours                      1 (1-2)             1 (1-2)            1.1 (1-2)           0.82
   C~12\ h\'~mg/L                     2.4 (1.5-4.1)       3.7 (2.3-4.9)      1.5 (0.6-2.1)       0.008
  MPAG pharmacokinetic parameters                                                                
   AUC~0-12\ h\'~mg·hour/L            775.3 (475-1,026)   791 (635-1,166)    678.8 (426-840.6)   0.22
   T~max\'~hours                      2 (2-3)             2.3 (2-3)          1.3 (1-2)           0.01
   C~12\ h\'~mg/L                     32.1 (24.3-41.9)    34.7 (26.4-49.2)   29.8 (15.5-40)      0.26
  MPAG/MPA AUC~0-12\ h~ratio          11.5 (8.3-20.7)     10.9 (6.2-14.8)    18.7 (14.1-22.7)    0.07
  MPAG/MPA C~12\ h~ratio              11.5 (6.8-17.3)     10.2 (6.3-15)      18.7 (11.5-47.2)    0.02

Values are expressed as median (interquartile range) unless stated otherwise. ^a^Mann-Whitney *U*test; ^b^Fisher exact test. AUC~0-12\ h\'~area under the plasma concentration-versus-time curves for hours 0 to 12; C~12\ h\'~12-hour trough concentration; C~max\'~maximal concentration; GFR, glomerular filtration rate (estimated with the Cockcroft-Gault formula); MMF, mycophenolate mofetil; MPA, mycophenolic acid; MPAG, mycophenolic acid glucuronide; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index; T~max\'~time to maximal concentration.

The correct table is given here as Table [1](#T1){ref-type="table"}.
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